Jean-Michel Malbrancq

Dell, Inc. engages in the manufacture of electronic devices. Its products include laptops, desktops, tablets, thin clients, printers, monitors, software, workstations and accessories. The company was founded by Michael Saul Dell on February 1, 1984 and is headquartered in Round Rock, TX.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Part of Boston Scientific Corp., Meadox Medicals, Inc. makes vascular replacement devices. The private company is based in Oakland, NJ. Meadox Medicals was acquired by Boston Scientific Corp. on November 20, 1995 for $425 million.

Sebia SA engages in the provison of clinical protein electrophoresis equipment and reagent. It offers scientific and technical support, user training, and field services training. The firm also developed phoresis core, a management software for Sebia instruments. Its products include capillary and gel electrophesis. The company was founded in 1967 and is headquartered in Lisses, France.

Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland.

Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris.

MyoPowers Medical Technologies France SA operates as a medical device company. It specializes in muscle technologies to restore or improve muscle function. The firm also develops implantable medical devices for the treatment of severe stress urinary incontinence. The company was founded by Piergiorgio Tozzi and Daniel Hyoz in June 2004 and is headquartered in Lausanne, Switzerland.

MBDA France SAS designs and manufactures missiles and missile systems. It provides air dominance, battlefield management, ground based air defence, and maritime superiority. The company was founded in December 2001 and is headquartered in Paris, France.

Sebia Italia Srl provides wholesales medical equipment services. The company was founded in 1976 and is headquartered in Bagno a Ripoli, Italy.

Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom.

Part of Sebia SA, Sebia (UK) Ltd. is a British company founded in 2006 that offers a wide range of automated solutions for capillary electrophoresis, a next-generation separation method used for diabetes diagnosis. The private company is based in Camberley, UK. Sebia Academy, an exclusive service for continuing education courses, aims to share scientific and medical content with their customers.

Part of Sebia SA, Diacine France SAS develops diagnostics solutions for biologists and physicians in the fields of oncology and hemoglobin disorders. The private company is based in Lisses, France.

Germitec SA engages in the research, design, and marketing of medical hygiene systems. It develops Antigermix, which is used in disinfecting heat-sensitive medical instruments. The company was founded in 2005 and is headquartered in Ivry-sur-Seine, France.

CR Bard (Spain) manufactures medical devices. The private company is based in Barcelona, Spain.

ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith.

T-Heart SAS is an investment holding company with interest in research and development services on natural sciences sector. The company was founded on December 06, 2018 and is headquartered in Paris, France.

Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation.

Oncovita SAS is a biotech company based in Paris, France. Oncovita is developing a virus-derived vaccine technology to treat multiple types of cancers. The technology utilizes the natural anti-cancer and immunogenic properties of a harmless vaccine, making it a versatile platform. The MeasovirTM platform, derived from the safe and highly immunogenic measles vaccine virus, has clinically proven oncolytic potential and specifically targets and destroys cancer cells. The French company was founded in 2015 by Frédéric Tangy and is currently led by CEO Jean-François Le Bigot.

Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland.

Novostia SA is a Swiss company that manufactures medical devices. The company is based in Lausanne, Switzerland. The company was founded by Geoffroy Lapeyre. Alain Barbal has been the CEO of the company since 2021.

Amber Implants is a Dutch med-tech company that specializes in improving the quality of life of patients suffering from vertebral compression fractures (VCF). Amber Implants is based in The Hague, Netherlands. The company's flagship product is the VCfix® spinal system, which is a vertebral body augmentation system designed to provide pain control and stabilization of the spine. The company was founded in 2019 by Ahmadi Mohammad and Banafsheh Sajidi, with Banafsheh Sajidi serving as the CEO since its inception.

ArchiMed SAS (ArchiMed) is a private equity firm founded in 2014 by Cedric Berger, David Piccoli, and Vincent Guillaumot. The firm is headquartered in Lyon, France.